Cargando…
Circulating Biomarkers for Therapeutic Monitoring of Anti-cancer Agents
Circulating biomarkers have emerged as valuable surrogates for evaluating disease states in solid malignancies. Their relative ease of access and rapid turnover has bolstered clinical applications in monitoring treatment efficacy and cancer progression. In this review, the roles of various circulati...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074993/ https://www.ncbi.nlm.nih.gov/pubmed/35285488 http://dx.doi.org/10.1093/oncolo/oyac047 |